Adams Street Partners »

Mineralys Therapeutics shares owned by Adams Street Partners

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Adams Street Partners from 13F filings

Historical chart of Adams Street Partners investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Adams Street Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Adams Street Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $22M 2.3M 9.51
2023-06-30 $41M 2.4M 17.05
2023-03-31 $38M 2.4M 15.66

More positions owned by Adams Street Partners

Paylocity Holding Corporation Common (PCTY)
Rimini Street Common (RMNI)
PDD Holdings Ads (PDD)
Q2 Holdings Common (QTWO)
Mineralys Therapeutics Common (MLYS)
Vacasa Common- Class A
Icosavax Common
Fusion Pharmaceuticals Common (FUSN)
Corvus Pharmaceuticals Common (CRVS)
Sprinklr Common-Class A (CXM)
UiPath Common- Class A (PATH)
Freshworks Common- Class A (FRSH)
Affirm Holdings Common-Class A (AFRM)
Braze Common-Class A (BRZE)

View all positions for Adams Street Partners

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments
Walleye Trading Advisors

View all funds holding Mineralys Therapeutics